FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

150011000001103: Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16601901000001118 Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16602001000001114 Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) Is a Product containing precisely naproxen 250 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) Is a Naproxen 250mg tablets true Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) Has active ingredient Naproxen false Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) Has specific active ingredient Naproxen true Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) 250 tablet Is pack of False Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets Is pack of False Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) 250 tablet Has AMP True Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier
Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets Has AMP True Naproxen 250mg tablets (IVAX Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start